CB Technologies, Inc. was co-founded in 1993 by current CEO James L. Coyneand today employs over 115 people. CB develops and delivers technology toolsand services for life sciences companies. The company\'s cornerstone solutionis the MetaTrial(TM) suite of clinical software tools, including electronicdata capture (EDC) software. CB is headquartered in Philadelphia with officesin Boston, New York, Raleigh-Durham, Chicago, San Francisco, and London.